If left untreated, pancreatitis can lead to serious complications, including organ failure
View Study Bhasin, S., et al
This is the actual biological process where continuous stimulation of the GLP-1 receptor causes it to become less responsive
Phase 3 Development & Timeline Orforglipron's Phase 3 clinical development program is one of the most comprehensive in the history of obesity and diabetes pharmacotherapy, encompassing multiple trials across two parallel programs: the ATTAIN series for obesity indications and the ACHIEVE series for type 2 diabetes
Were seeing people who want to shed a few pounds wanting to use these drugs as well, and I do get the appeal
Most clinical evidence linking GLP-1 use to IBS improvement comes from observational data rather than randomized controlled trials, meaning causality cannot be definitively established